Literature DB >> 28891741

eRNA binding produces tailored CBP activity profiles to regulate gene expression.

Daniel A Bose1,2, Shelley L Berger3,4.   

Abstract

Enhancers are cis- regulatory genetic elements crucial for controlling temporal and cell-type specific patterns of gene expression. Active enhancers generate bi-directional non-coding RNA transcripts called enhancer RNAs (eRNAs). eRNAs are important for stimulating gene expression, but precise mechanisms for this ability remain unclear. Here we highlight recent findings that demonstrate a direct interaction between RNAs and the transcriptional co-activator Creb-binding protein (CBP). Notably, RNA binding could stimulate the core histone acetyltransferase activity of the enzyme, observable in cells as a link between eRNA production, CBP-dependent histone acetylation and expression of genes regulated by specific enhancers. Although RNA binding was independent of RNA sequence, specificity arises in a locus-specific manner at transcribed sites where CBP was bound to chromatin. The results suggest a functional role for eRNAs as regulatory molecules that are able to stimulate the activity of a key epigenetic regulatory enzyme, thereby promoting gene expression. Furthermore, they suggest an intriguing role for eRNAs: by modulating the activity of chromatin modifying enzymes, they could directly impact transcription by altering the chromatin environment.

Entities:  

Keywords:  chromatin modification; eRNA; epigenetic enzymes; gene regulation; non-coding RNA

Mesh:

Substances:

Year:  2017        PMID: 28891741      PMCID: PMC5731803          DOI: 10.1080/15476286.2017.1353862

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  33 in total

Review 1.  Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases.

Authors:  David C Bedford; Lawryn H Kasper; Tomofusa Fukuyama; Paul K Brindle
Journal:  Epigenetics       Date:  2010-01-27       Impact factor: 4.528

2.  Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation.

Authors:  Manuela Delvecchio; Jonathan Gaucher; Carmen Aguilar-Gurrieri; Esther Ortega; Daniel Panne
Journal:  Nat Struct Mol Biol       Date:  2013-08-11       Impact factor: 15.369

3.  Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.

Authors:  Minna U Kaikkonen; Nathanael J Spann; Sven Heinz; Casey E Romanoski; Karmel A Allison; Joshua D Stender; Hyun B Chun; David F Tough; Rab K Prinjha; Christopher Benner; Christopher K Glass
Journal:  Mol Cell       Date:  2013-08-08       Impact factor: 17.970

4.  Promiscuous RNA binding by Polycomb repressive complex 2.

Authors:  Chen Davidovich; Leon Zheng; Karen J Goodrich; Thomas R Cech
Journal:  Nat Struct Mol Biol       Date:  2013-09-29       Impact factor: 15.369

5.  iCLIP: protein-RNA interactions at nucleotide resolution.

Authors:  Ina Huppertz; Jan Attig; Andrea D'Ambrogio; Laura E Easton; Christopher R Sibley; Yoichiro Sugimoto; Mojca Tajnik; Julian König; Jernej Ule
Journal:  Methods       Date:  2013-10-25       Impact factor: 3.608

6.  DNMT1-interacting RNAs block gene-specific DNA methylation.

Authors:  Annalisa Di Ruscio; Alexander K Ebralidze; Touati Benoukraf; Giovanni Amabile; Loyal A Goff; Jolyon Terragni; Maria Eugenia Figueroa; Lorena Lobo De Figueiredo Pontes; Meritxell Alberich-Jorda; Pu Zhang; Mengchu Wu; Francesco D'Alò; Ari Melnick; Giuseppe Leone; Konstantin K Ebralidze; Sriharsa Pradhan; John L Rinn; Daniel G Tenen
Journal:  Nature       Date:  2013-10-09       Impact factor: 49.962

7.  Essential role of lncRNA binding for WDR5 maintenance of active chromatin and embryonic stem cell pluripotency.

Authors:  Yul W Yang; Ryan A Flynn; Yong Chen; Kun Qu; Bingbing Wan; Kevin C Wang; Ming Lei; Howard Y Chang
Journal:  Elife       Date:  2014-02-12       Impact factor: 8.140

8.  Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription.

Authors:  Michael T Y Lam; Han Cho; Hanna P Lesch; David Gosselin; Sven Heinz; Yumiko Tanaka-Oishi; Christopher Benner; Minna U Kaikkonen; Aneeza S Kim; Mika Kosaka; Cindy Y Lee; Andy Watt; Tamar R Grossman; Michael G Rosenfeld; Ronald M Evans; Christopher K Glass
Journal:  Nature       Date:  2013-06-02       Impact factor: 49.962

9.  Comprehensive Identification of RNA-Binding Domains in Human Cells.

Authors:  Alfredo Castello; Bernd Fischer; Christian K Frese; Rastislav Horos; Anne-Marie Alleaume; Sophia Foehr; Tomaz Curk; Jeroen Krijgsveld; Matthias W Hentze
Journal:  Mol Cell       Date:  2016-07-21       Impact factor: 17.970

10.  Widespread RNA binding by chromatin-associated proteins.

Authors:  David G Hendrickson; David R Kelley; Danielle Tenen; Bradley Bernstein; John L Rinn
Journal:  Genome Biol       Date:  2016-02-16       Impact factor: 13.583

View more
  11 in total

Review 1.  Regulation of epigenetic state by non-histone chromatin proteins and transcription factors: Implications in disease.

Authors:  Sweta Sikder; Stephanie Kaypee; Tapas K Kundu
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

Review 2.  Exploring the secrets of brain transcriptional regulation: developing methodologies, recent significant findings, and perspectives.

Authors:  Zhe Ding; Luyun Sun; Cen Yang; Aihua Liu; Fukai Bao
Journal:  Brain Struct Funct       Date:  2021-02-05       Impact factor: 3.270

Review 3.  From enhanceropathies to the epigenetic manifold underlying human cognition.

Authors:  Alessandro Vitriolo; Michele Gabriele; Giuseppe Testa
Journal:  Hum Mol Genet       Date:  2019-11-21       Impact factor: 6.150

4.  An Integrative Analysis Revealing ZFHX4-AS1 as a Novel Prognostic Biomarker Correlated with Immune Infiltrates in Ovarian Cancer.

Authors:  Changchang Huang; Hongyin Cui; Xiaolin Lang; Fen Zhao
Journal:  J Immunol Res       Date:  2022-06-26       Impact factor: 4.493

Review 5.  Epigenome Interactions with Patterned Neuronal Activity.

Authors:  Jillian Belgrad; R Douglas Fields
Journal:  Neuroscientist       Date:  2018-02-27       Impact factor: 7.519

Review 6.  Current Advances on the Important Roles of Enhancer RNAs in Gene Regulation and Cancer.

Authors:  Yuhan Liu; Mengting Ding; Qunjun Gao; Anbang He; Yuchen Liu; Hongbing Mei
Journal:  Biomed Res Int       Date:  2018-05-22       Impact factor: 3.411

Review 7.  Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease Treatment.

Authors:  Mengting Ding; Yuhan Liu; Xinhui Liao; Hengji Zhan; Yuchen Liu; Weiren Huang
Journal:  J Cancer       Date:  2018-06-06       Impact factor: 4.207

8.  MyoD induced enhancer RNA interacts with hnRNPL to activate target gene transcription during myogenic differentiation.

Authors:  Yu Zhao; Jiajian Zhou; Liangqiang He; Yuying Li; Jie Yuan; Kun Sun; Xiaona Chen; Xichen Bao; Miguel A Esteban; Hao Sun; Huating Wang
Journal:  Nat Commun       Date:  2019-12-19       Impact factor: 14.919

9.  Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma.

Authors:  Su Zhao; Hao Jiang; Jing Liu; Dao-Yuan Li; Bing Li; Qiu-Rong Long; Lei Zheng; Hao Gu
Journal:  Dis Markers       Date:  2022-02-23       Impact factor: 3.434

10.  ADRAM is an experience-dependent long noncoding RNA that drives fear extinction through a direct interaction with the chaperone protein 14-3-3.

Authors:  Wei Wei; Qiongyi Zhao; Ziqi Wang; Wei-Siang Liau; Dean Basic; Haobin Ren; Paul R Marshall; Esmi L Zajaczkowski; Laura J Leighton; Sachithrani U Madugalle; Mason Musgrove; Ambika Periyakaruppiah; Jichun Shi; Jianjian Zhang; John S Mattick; Timothy R Mercer; Robert C Spitale; Xiang Li; Timothy W Bredy
Journal:  Cell Rep       Date:  2022-03-22       Impact factor: 9.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.